Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px
Document › Details

Paion AG. (5/9/12). "Press Release: Interim Report by Management for the First Half [correct: Quarter, iito] of the Year 2012 according to § 37X WPHG for the Period fom 1 January to 31 March 2012". Aachen.

Organisations Organisation Paion AG
  Group Paion (Group)
  Organisation 2 H. Lundbeck A/S
  Group Lundbeck (Group)
Products Product desmoteplase
  Product 2 remimazolam (CNS 7056)
  Index term 2 Lundbeck–Paion: desmoteplase, 201202 acquisition all remaining desmoteplase rights for €20.1m in cash from Paion
Person Person Söhngen, Wolfgang (Paion 200603 CEO)
     


   
Record changed: 2017-04-02

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

More documents for Paion (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top